APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

New Medical Materials and Biomaterials

New Medical Materials and Biomaterials is newly developed materials for medical devices, tools, and other things (excluding drugs).

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

New Medical Materials and Biomaterials is newly developed materials for medical devices, tools, and other things (excluding drugs).

Selected research

Market Outlook & Growth Opportunities

Global New Medical Materials and Biomaterials Market Outlook and Growth Opportunities 2026

Report ID 173317140423 December 2025196 pages

Choose your research edition.

Industry ResearchNew Medical Materials and Biomaterials Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal New Medical Materials and Biomaterials Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal New Medical Materials and Biomaterials Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal New Medical Materials and Biomaterials Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal New Medical Materials and Biomaterials Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

New Medical Materials and Biomaterials is newly developed materials for medical devices, tools, and other things (excluding drugs).

In US, New Medical Materials and Biomaterials key players include STR, Avitus, Sagemax, Stratasys, Formlab, etc.

In terms of product, Bioceramics is the largest segment, with a share over 20%. And in terms of application, the largest application is Catheters, followed by Dental Products, Transplant Components, etc.

Read the full market overview

This report provides an overview of the global New Medical Materials and Biomaterials market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of New Medical Materials and Biomaterials and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents New Medical Materials and Biomaterials revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global New Medical Materials and Biomaterials market.

New Medical Materials and Biomaterials Segment by Company

STR

Avitus

Sagemax

Stratasys

Formlab

NanoH2O (LG)

Covalent-coating

Nasseo

TriboFilm

ACS material

Palmaz Scientific

Invibio

Secant Medical

TeraPore Technologies

New Medical Materials and Biomaterials Segment by Type

Medical Polymers

Bioceramics

Medical 3D Printing Materials

Membranes

Surface Modifications

Others

New Medical Materials and Biomaterials Segment by Application

Packaging

Transplant Components

Dental Products

Catheters

Others

New Medical Materials and Biomaterials Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global New Medical Materials and Biomaterials status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the New Medical Materials and Biomaterials key companies, revenue, market share, and recent developments.

3. To split the New Medical Materials and Biomaterials breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions New Medical Materials and Biomaterials market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify New Medical Materials and Biomaterials significant trends, drivers, influence factors in global and regions.

6. To analyze New Medical Materials and Biomaterials competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global New Medical Materials and Biomaterials market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of New Medical Materials and Biomaterials and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of New Medical Materials and Biomaterials.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global New Medical Materials and Biomaterials industry.

Chapter 3: Detailed analysis of New Medical Materials and Biomaterials company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of New Medical Materials and Biomaterials in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of New Medical Materials and Biomaterials in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. New Medical Materials and Biomaterials Industry Trends Table 2. New Medical Materials and Biomaterials Industry Drivers Table 3. New Medical Materials and Biomaterials Industry Opportunities and Challenges Table 4. New Medical Materials and Biomaterials Industry Restraints Table 5. Global New Medical Materials and Biomaterials Revenue by Company (US$ Million) & (2021-2026) Table 6. Global New Medical Materials and Biomaterials Revenue Share by Company (2021-2026) Table 7. Global New Medical Materials and Biomaterials Company Ranking, (2024-2026) & (US$ Million) Table 8. Global New Medical Materials and Biomaterials Key Company Manufacturing Base & Headquarters Table 9. Global New Medical Materials and Biomaterials Company, Product Type & Application Table 10. Global New Medical Materials and Biomaterials Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global New Medical Materials and Biomaterials by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Medical Polymers Table 15. Significant Companies of Bioceramics Table 16. Significant Companies of Medical 3D Printing Materials Table 17. Significant Companies of Membranes Table 18. Significant Companies of Surface Modifications Table 19. Significant Companies of Others Table 20. Global New Medical Materials and Biomaterials Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global New Medical Materials and Biomaterials Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global New Medical Materials and Biomaterials Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global New Medical Materials and Biomaterials Sales Value Share by Type (2021-2026) Table 24. Global New Medical Materials and Biomaterials Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Packaging Table 26. Significant Companies of Transplant Components Table 27. Significant Companies of Dental Products Table 28. Significant Companies of Catheters Table 29. Significant Companies of Others Table 30. Global New Medical Materials and Biomaterials Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global New Medical Materials and Biomaterials Sales Value by Application (2021-2026) & (US$ Million) Table 32. Global New Medical Materials and Biomaterials Sales Value by Application (2027-2032) & (US$ Million) Table 33. Global New Medical Materials and Biomaterials Sales Value Share by Application (2021-2026) Table 34. Global New Medical Materials and Biomaterials Sales Value Share by Application (2027-2032) Table 35. Global New Medical Materials and Biomaterials Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global New Medical Materials and Biomaterials Sales Value by Region (2021-2026) & (US$ Million) Table 37. Global New Medical Materials and Biomaterials Sales Value Share by Region (2021-2026) Table 38. Global New Medical Materials and Biomaterials Sales Value by Region (2027-2032) & (US$ Million) Table 39. Global New Medical Materials and Biomaterials Sales Value Share by Region (2027-2032) Table 40. Global New Medical Materials and Biomaterials Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global New Medical Materials and Biomaterials Sales Value by Country (2021-2026) & (US$ Million) Table 42. Global New Medical Materials and Biomaterials Sales Value Market Share by Country (2021-2026) Table 43. Global New Medical Materials and Biomaterials Sales Value by Country (2027-2032) & (US$ Million) Table 44. Global New Medical Materials and Biomaterials Sales Value Market Share by Country (2027-2032) Table 45. STR Company Information Table 46. STR Business Overview Table 47. STR New Medical Materials and Biomaterials Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. STR New Medical Materials and Biomaterials Product Portfolio Table 49. STR Recent Development Table 50. Avitus Company Information Table 51. Avitus Business Overview Table 52. Avitus New Medical Materials and Biomaterials Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Avitus New Medical Materials and Biomaterials Product Portfolio Table 54. Avitus Recent Development Table 55. Sagemax Company Information Table 56. Sagemax Business Overview Table 57. Sagemax New Medical Materials and Biomaterials Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Sagemax New Medical Materials and Biomaterials Product Portfolio Table 59. Sagemax Recent Development Table 60. Stratasys Company Information Table 61. Stratasys Business Overview Table 62. Stratasys New Medical Materials and Biomaterials Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Stratasys New Medical Materials and Biomaterials Product Portfolio Table 64. Stratasys Recent Development Table 65. Formlab Company Information Table 66. Formlab Business Overview Table 67. Formlab New Medical Materials and Biomaterials Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Formlab New Medical Materials and Biomaterials Product Portfolio Table 69. Formlab Recent Development Table 70. NanoH2O (LG) Company Information Table 71. NanoH2O (LG) Business Overview Table 72. NanoH2O (LG) New Medical Materials and Biomaterials Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. NanoH2O (LG) New Medical Materials and Biomaterials Product Portfolio Table 74. NanoH2O (LG) Recent Development Table 75. Covalent-coating Company Information Table 76. Covalent-coating Business Overview Table 77. Covalent-coating New Medical Materials and Biomaterials Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Covalent-coating New Medical Materials and Biomaterials Product Portfolio Table 79. Covalent-coating Recent Development Table 80. Nasseo Company Information Table 81. Nasseo Business Overview Table 82. Nasseo New Medical Materials and Biomaterials Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Nasseo New Medical Materials and Biomaterials Product Portfolio Table 84. Nasseo Recent Development Table 85. TriboFilm Company Information Table 86. TriboFilm Business Overview Table 87. TriboFilm New Medical Materials and Biomaterials Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. TriboFilm New Medical Materials and Biomaterials Product Portfolio Table 89. TriboFilm Recent Development Table 90. ACS material Company Information Table 91. ACS material Business Overview Table 92. ACS material New Medical Materials and Biomaterials Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. ACS material New Medical Materials and Biomaterials Product Portfolio Table 94. ACS material Recent Development Table 95. Palmaz Scientific Company Information Table 96. Palmaz Scientific Business Overview Table 97. Palmaz Scientific New Medical Materials and Biomaterials Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 98. Palmaz Scientific New Medical Materials and Biomaterials Product Portfolio Table 99. Palmaz Scientific Recent Development Table 100. Invibio Company Information Table 101. Invibio Business Overview Table 102. Invibio New Medical Materials and Biomaterials Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 103. Invibio New Medical Materials and Biomaterials Product Portfolio Table 104. Invibio Recent Development Table 105. Secant Medical Company Information Table 106. Secant Medical Business Overview Table 107. Secant Medical New Medical Materials and Biomaterials Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 108. Secant Medical New Medical Materials and Biomaterials Product Portfolio Table 109. Secant Medical Recent Development Table 110. TeraPore Technologies Company Information Table 111. TeraPore Technologies Business Overview Table 112. TeraPore Technologies New Medical Materials and Biomaterials Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 113. TeraPore Technologies New Medical Materials and Biomaterials Product Portfolio Table 114. TeraPore Technologies Recent Development Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. New Medical Materials and Biomaterials Product Image Figure 2. Global New Medical Materials and Biomaterials Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global New Medical Materials and Biomaterials Market Size (2021-2032) & (US$ Million) Figure 4. Global New Medical Materials and Biomaterials Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Medical Polymers Image Figure 8. Bioceramics Image Figure 9. Medical 3D Printing Materials Image Figure 10. Membranes Image Figure 11. Surface Modifications Image Figure 12. Others Image Figure 13. Global New Medical Materials and Biomaterials Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global New Medical Materials and Biomaterials Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global New Medical Materials and Biomaterials Sales Value Share by Type (2021-2032) Figure 16. Packaging Image Figure 17. Transplant Components Image Figure 18. Dental Products Image Figure 19. Catheters Image Figure 20. Others Image Figure 21. Global New Medical Materials and Biomaterials Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global New Medical Materials and Biomaterials Sales Value Share 2021 VS 2025 VS 2032 Figure 23. Global New Medical Materials and Biomaterials Sales Value Share by Application (2021-2032) Figure 24. Global New Medical Materials and Biomaterials Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 25. Global New Medical Materials and Biomaterials Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 26. North America New Medical Materials and Biomaterials Sales Value (2021-2032) & (US$ Million) Figure 27. North America New Medical Materials and Biomaterials Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Europe New Medical Materials and Biomaterials Sales Value (2021-2032) & (US$ Million) Figure 29. Europe New Medical Materials and Biomaterials Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Asia-Pacific New Medical Materials and Biomaterials Sales Value (2021-2032) & (US$ Million) Figure 31. Asia-Pacific New Medical Materials and Biomaterials Sales Value Share by Country (%), 2025 VS 2032 Figure 32. South America New Medical Materials and Biomaterials Sales Value (2021-2032) & (US$ Million) Figure 33. South America New Medical Materials and Biomaterials Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Middle East & Africa New Medical Materials and Biomaterials Sales Value (2021-2032) & (US$ Million) Figure 35. Middle East & Africa New Medical Materials and Biomaterials Sales Value Share by Country (%), 2025 VS 2032 Figure 36. USA New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. USA New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. USA New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Canada New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Canada New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Canada New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Mexico New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Mexico New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Mexico New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Germany New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Germany New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Germany New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. France New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. France New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. France New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. U.K. New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. U.K. New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. U.K. New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Italy New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Italy New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Italy New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Spain New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Spain New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Spain New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Russia New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Russia New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Russia New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Netherlands New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Netherlands New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Netherlands New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Nordic Countries New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Nordic Countries New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Nordic Countries New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. China New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. China New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. China New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Japan New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Japan New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Japan New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. South Korea New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. South Korea New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. South Korea New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. India New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. India New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. India New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Australia New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Australia New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Australia New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Southeast Asia New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Southeast Asia New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Southeast Asia New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Brazil New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Brazil New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Brazil New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Argentina New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Argentina New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Argentina New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Chile New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Chile New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Chile New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Colombia New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Colombia New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Colombia New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Peru New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Peru New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Peru New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Saudi Arabia New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Saudi Arabia New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Saudi Arabia New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Israel New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Israel New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Israel New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. UAE New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. UAE New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. UAE New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Turkey New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Turkey New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Turkey New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Iran New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Iran New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Iran New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Egypt New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Egypt New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Egypt New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Years Considered Figure 121. Research Process Figure 122. Key Executives Interviewed

Scope & coverage.

Types
  • Medical Polymers
  • Bioceramics
  • Medical 3D Printing Materials
  • Membranes
  • Surface Modifications
  • Others
Applications
  • Packaging
  • Transplant Components
  • Dental Products
  • Catheters
  • Others
Companies covered
  • STR
  • Avitus
  • Sagemax
  • Stratasys
  • Formlab
  • NanoH2O (LG)
  • Covalent-coating
  • Nasseo
  • TriboFilm
  • ACS material
  • Palmaz Scientific
  • Invibio
  • Secant Medical
  • TeraPore Technologies

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global New Medical Materials and Biomaterials Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global New Medical Materials and Biomaterials Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 New Medical Materials and Biomaterials Market Dynamics
  1. 2.1 New Medical Materials and Biomaterials Industry Trends
  2. 2.2 New Medical Materials and Biomaterials Industry Drivers
  3. 2.3 New Medical Materials and Biomaterials Industry Opportunities and Challenges
  4. 2.4 New Medical Materials and Biomaterials Industry Restraints
3 New Medical Materials and Biomaterials Market by Company
  1. 3.1 Global New Medical Materials and Biomaterials Company Revenue Ranking in 2025
  2. 3.2 Global New Medical Materials and Biomaterials Revenue by Company (2021-2026)
  3. 3.3 Global New Medical Materials and Biomaterials Company Ranking (2024-2026)
  4. 3.4 Global New Medical Materials and Biomaterials Company Manufacturing Base and Headquarters
  5. 3.5 Global New Medical Materials and Biomaterials Company Product Type and Application
  6. 3.6 Global New Medical Materials and Biomaterials Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global New Medical Materials and Biomaterials Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 New Medical Materials and Biomaterials Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 New Medical Materials and Biomaterials Market by Type
  1. 4.1 New Medical Materials and Biomaterials Type Introduction
  2. 4.1.1 Medical Polymers
  3. 4.1.2 Bioceramics
  4. 4.1.3 Medical 3D Printing Materials
  5. 4.1.4 Membranes
  6. 4.1.5 Surface Modifications
  7. 4.1.6 Others
  8. 4.2 Global New Medical Materials and Biomaterials Sales Value by Type
  9. 4.2.1 Global New Medical Materials and Biomaterials Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global New Medical Materials and Biomaterials Sales Value by Type (2021-2032)
  11. 4.2.3 Global New Medical Materials and Biomaterials Sales Value Share by Type (2021-2032)
5 New Medical Materials and Biomaterials Market by Application
  1. 5.1 New Medical Materials and Biomaterials Application Introduction
  2. 5.1.1 Packaging
  3. 5.1.2 Transplant Components
  4. 5.1.3 Dental Products
  5. 5.1.4 Catheters
  6. 5.1.5 Others
  7. 5.2 Global New Medical Materials and Biomaterials Sales Value by Application
  8. 5.2.1 Global New Medical Materials and Biomaterials Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global New Medical Materials and Biomaterials Sales Value by Application (2021-2032)
  10. 5.2.3 Global New Medical Materials and Biomaterials Sales Value Share by Application (2021-2032)
6 New Medical Materials and Biomaterials Regional Value Analysis
  1. 6.1 Global New Medical Materials and Biomaterials Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global New Medical Materials and Biomaterials Sales Value by Region (2021-2032)
  3. 6.2.1 Global New Medical Materials and Biomaterials Sales Value by Region: 2021-2026
  4. 6.2.2 Global New Medical Materials and Biomaterials Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America New Medical Materials and Biomaterials Sales Value (2021-2032)
  7. 6.3.2 North America New Medical Materials and Biomaterials Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe New Medical Materials and Biomaterials Sales Value (2021-2032)
  10. 6.4.2 Europe New Medical Materials and Biomaterials Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific New Medical Materials and Biomaterials Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific New Medical Materials and Biomaterials Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America New Medical Materials and Biomaterials Sales Value (2021-2032)
  16. 6.6.2 South America New Medical Materials and Biomaterials Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa New Medical Materials and Biomaterials Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa New Medical Materials and Biomaterials Sales Value Share by Country, 2025 VS 2032
7 New Medical Materials and Biomaterials Country-level Value Analysis
  1. 7.1 Global New Medical Materials and Biomaterials Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global New Medical Materials and Biomaterials Sales Value by Country (2021-2032)
  3. 7.2.1 Global New Medical Materials and Biomaterials Sales Value by Country (2021-2026)
  4. 7.2.2 Global New Medical Materials and Biomaterials Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt New Medical Materials and Biomaterials Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt New Medical Materials and Biomaterials Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt New Medical Materials and Biomaterials Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 STR
  2. 8.1.1 STR Company Information
  3. 8.1.2 STR Business Overview
  4. 8.1.3 STR New Medical Materials and Biomaterials Revenue and Gross Margin (2021-2026)
  5. 8.1.4 STR New Medical Materials and Biomaterials Product Portfolio
  6. 8.1.5 STR Recent Developments
  7. 8.2 Avitus
  8. 8.2.1 Avitus Company Information
  9. 8.2.2 Avitus Business Overview
  10. 8.2.3 Avitus New Medical Materials and Biomaterials Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Avitus New Medical Materials and Biomaterials Product Portfolio
  12. 8.2.5 Avitus Recent Developments
  13. 8.3 Sagemax
  14. 8.3.1 Sagemax Company Information
  15. 8.3.2 Sagemax Business Overview
  16. 8.3.3 Sagemax New Medical Materials and Biomaterials Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sagemax New Medical Materials and Biomaterials Product Portfolio
  18. 8.3.5 Sagemax Recent Developments
  19. 8.4 Stratasys
  20. 8.4.1 Stratasys Company Information
  21. 8.4.2 Stratasys Business Overview
  22. 8.4.3 Stratasys New Medical Materials and Biomaterials Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Stratasys New Medical Materials and Biomaterials Product Portfolio
  24. 8.4.5 Stratasys Recent Developments
  25. 8.5 Formlab
  26. 8.5.1 Formlab Company Information
  27. 8.5.2 Formlab Business Overview
  28. 8.5.3 Formlab New Medical Materials and Biomaterials Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Formlab New Medical Materials and Biomaterials Product Portfolio
  30. 8.5.5 Formlab Recent Developments
  31. 8.6 NanoH2O (LG)
  32. 8.6.1 NanoH2O (LG) Company Information
  33. 8.6.2 NanoH2O (LG) Business Overview
  34. 8.6.3 NanoH2O (LG) New Medical Materials and Biomaterials Revenue and Gross Margin (2021-2026)
  35. 8.6.4 NanoH2O (LG) New Medical Materials and Biomaterials Product Portfolio
  36. 8.6.5 NanoH2O (LG) Recent Developments
  37. 8.7 Covalent-coating
  38. 8.7.1 Covalent-coating Company Information
  39. 8.7.2 Covalent-coating Business Overview
  40. 8.7.3 Covalent-coating New Medical Materials and Biomaterials Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Covalent-coating New Medical Materials and Biomaterials Product Portfolio
  42. 8.7.5 Covalent-coating Recent Developments
  43. 8.8 Nasseo
  44. 8.8.1 Nasseo Company Information
  45. 8.8.2 Nasseo Business Overview
  46. 8.8.3 Nasseo New Medical Materials and Biomaterials Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Nasseo New Medical Materials and Biomaterials Product Portfolio
  48. 8.8.5 Nasseo Recent Developments
  49. 8.9 TriboFilm
  50. 8.9.1 TriboFilm Company Information
  51. 8.9.2 TriboFilm Business Overview
  52. 8.9.3 TriboFilm New Medical Materials and Biomaterials Revenue and Gross Margin (2021-2026)
  53. 8.9.4 TriboFilm New Medical Materials and Biomaterials Product Portfolio
  54. 8.9.5 TriboFilm Recent Developments
  55. 8.10 ACS material
  56. 8.10.1 ACS material Company Information
  57. 8.10.2 ACS material Business Overview
  58. 8.10.3 ACS material New Medical Materials and Biomaterials Revenue and Gross Margin (2021-2026)
  59. 8.10.4 ACS material New Medical Materials and Biomaterials Product Portfolio
  60. 8.10.5 ACS material Recent Developments
  61. 8.11 Palmaz Scientific
  62. 8.11.1 Palmaz Scientific Company Information
  63. 8.11.2 Palmaz Scientific Business Overview
  64. 8.11.3 Palmaz Scientific New Medical Materials and Biomaterials Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Palmaz Scientific New Medical Materials and Biomaterials Product Portfolio
  66. 8.11.5 Palmaz Scientific Recent Developments
  67. 8.12 Invibio
  68. 8.12.1 Invibio Company Information
  69. 8.12.2 Invibio Business Overview
  70. 8.12.3 Invibio New Medical Materials and Biomaterials Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Invibio New Medical Materials and Biomaterials Product Portfolio
  72. 8.12.5 Invibio Recent Developments
  73. 8.13 Secant Medical
  74. 8.13.1 Secant Medical Company Information
  75. 8.13.2 Secant Medical Business Overview
  76. 8.13.3 Secant Medical New Medical Materials and Biomaterials Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Secant Medical New Medical Materials and Biomaterials Product Portfolio
  78. 8.13.5 Secant Medical Recent Developments
  79. 8.14 TeraPore Technologies
  80. 8.14.1 TeraPore Technologies Company Information
  81. 8.14.2 TeraPore Technologies Business Overview
  82. 8.14.3 TeraPore Technologies New Medical Materials and Biomaterials Revenue and Gross Margin (2021-2026)
  83. 8.14.4 TeraPore Technologies New Medical Materials and Biomaterials Product Portfolio
  84. 8.14.5 TeraPore Technologies Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst